Apyx Medical Corporation Initiates Public Offering
Recently, Apyx Medical Corporation (Nasdaq: APYX) proudly announced its decision to commence an underwritten public offering of common stock. This strategic move is pivotal in solidifying Apyx as a leader in the surgical aesthetics space, specifically with its acclaimed brands Renuvion and the AYON Body Contouring System.
Details of the Offering
The public offering is designed to adapt to current market conditions. While there is enthusiasm surrounding the offering, it is important to note that there are no guarantees regarding the completion of the offering, nor the size or specific terms at this moment.
Book-Running Manager
Lucid Capital Markets has been selected as the exclusive book-running manager for this exciting offering. Their expertise will help navigate Apyx through the complexities of the public offering process.
Prospectus and Regulatory Compliance
Apyx Medical's offering will adhere to the rules set forth by the Securities and Exchange Commission (SEC). The company has established a shelf registration statement on Form S-3, which allows for a streamlined process in which they can publicly offer shares in compliance with SEC regulations.
Availability of Prospectus
A preliminary prospectus supplement and accompanying prospectus detailing the offering will be filed with the SEC. Investors will have access to this information, promoting transparency as the company progresses. Those interested can obtain copies by contacting Lucid Capital Markets directly at 570 Lexington Avenue, 40th Floor, New York, NY.
Company Background
Apyx Medical Corporation is not merely a company; it embodies a mission centered on surgical aesthetics. With cutting-edge products such as the Renuvion and AYON Body Contouring System, Apyx is transforming the landscape of cosmetic surgery. The innovation behind these products is fundamentally tied to the company's Helium Plasma Platform Technology. This advanced technology allows for controlled delivery of heat to tissue, resulting in remarkable outcomes for patients.
Industry Impact and Innovations
Renuvion and J-Plasma are supported by extensive clinical research, with more than 90 documents validating their efficacy in various surgical settings. This robust support places Apyx in a competitive position in the cosmetic surgery market, providing unique solutions that address the needs of both surgeons and patients.
The AYON Body Contouring System is an efficient, FDA-cleared system designed by surgeons, ensuring that it meets the high standards and requirements of the field. Its multifunctional capabilities offer a comprehensive approach to body contouring, integrating fat removal with precision and tissue contraction.
Investment and Financial Considerations
The potential proceeds from the public offering are expected to enhance Apyx Medical's strategic initiatives, including further innovation and expansion within the surgical aesthetics market. With increasing demand for aesthetic procedures, Apyx is positioned to capitalize on the opportunity to grow its market share significantly.
Contact and Investor Relations
For those seeking more information about Apyx Medical and its offerings, please reach out to:
Jeremy Feffer, Managing Director LifeSci Advisors
OP: 212-915-2568
For inquiries, feel free to email jfeffer@lifesciadvisors.com.
Frequently Asked Questions
What is the purpose of the public offering by Apyx Medical?
The public offering aims to strengthen Apyx Medical's financial position and support future innovations and growth in the surgical aesthetics market.
Who is managing the public offering?
Lucid Capital Markets is the sole book-running manager overseeing the public offering.
How will the proceeds from the offering be used?
The proceeds are expected to be used to fund strategic initiatives, enhancing the company's capabilities in surgical aesthetics.
What products does Apyx Medical offer?
Apyx Medical specializes in surgical aesthetics with notable products including Renuvion and the AYON Body Contouring System.
Where can I find more information about Apyx Medical?
More information is available on the official Apyx Medical Corporation website at www.ApyxMedical.com.
